Cite
MLA Citation
Melissa A. Frasco et al.. “Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a.” Journal of medical economics, vol. 20, 2017, pp. 1074–1082. http://access.bl.uk/ark:/81055/vdc_100049476100.0x000035